Resource Allocation for Brain Research in Europe
The EBC has worked with Stockholm Health Economics to review the current level of resource allocation to brain research in the EU. Partly funded by the EC, RABRE sought to build on the EBC’s previous finding that brain diseases represent 35% of the burden of all diseases in Europe. RABRE analysed both private and public funding of brain research in Europe, and funding sources were categorised according to both function and disease target.
For more information, please click here.
- Resource Allocation to Brain Research in Europe - Full Report
- Resource Allocation to Brain Research in Europe (RABRE)
- Research Allocation to Brain Research in Europe - Appendices
- Executive summaries are available in: